UCB (EBR:UCB) UCB Media Room - Disposal of own shares

Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires

05/08/2022 20:00
https://mb.cision.com/Public/18595/3610800/ac752e88efb06bb5_800x800ar.png ** Disposal of own shares ------------------------------------------------------------ Brussels (Belgium), 5 August 2022 =E2=80=93 20:00 (CEST) =E2=80=93 Regulate= d information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long-Term Incentive Program of the UCB= Group, as follows: https://mb.cision.com/Public/18595/3610800/8c240bbbd1db9107_800x800ar.png In addition to these exercises, on 1 August 2022, in accordance with the ve= sting rules under its 2019, 2020 and 2021 LTI plan, UCB SA/NV has delivered= for free a total of 7 984 UCB shares OTC to 10 members of the personnel of= the Company and its subsidiaries. The highest independent bid price on Eur= onext Brussels on 1 August 2022 was =E2=82=AC 79.28. This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the= following link. (https://www.ucb.com/stories-media/Press-Releases) For further information, contact UCB: Investor Relations Antje Witte T +32 2 559 94 14 antje.witte@ucb.com (mailto:antje.witte@ucb.com) Corporate Communications Laurent Schots T+32 2 559 92 64 laurent.schots@ucb.com (mailto:laurent.schots@ucb.com) =C2=A0=C2=A0=C2=A0= =C2=A0=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 600 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi= llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news Image Disposal of own shares - 5 August 2022 (https://mb.cision.com/Public/18595/= 3610800/8c240bbbd1db9107_org.png) GenericFile 220508 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/36= 10800/8b9bd7fa6747c2ec.pdf) GenericFile 220805 - Alienation d'actions propres FR (https://mb.cision.com/Public/1859= 5/3610800/849db378fc8a4607.pdf) GenericFile 220508 - Vervreemding van eigen aandelen NL (https://mb.cision.com/Public/1= 8595/3610800/a3cca02bab9f0dda.pdf) ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x112837x1x6868579x2400= 0x6&Email=3Dregnews%40symexglobal.com. UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium